Jafron Biomedical Co.,Ltd. Stock

Equities

300529

CNE100002995

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
28.64 CNY -1.55% Intraday chart for Jafron Biomedical Co.,Ltd. +3.99% +28.83%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 2.88B 399M Sales 2025 * 3.45B 477M Capitalization 22.18B 3.07B
Net income 2024 * 808M 112M Net income 2025 * 1.02B 141M EV / Sales 2024 * 7.69 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 6.44 x
P/E ratio 2024 *
28.6 x
P/E ratio 2025 *
22.7 x
Employees 2,408
Yield 2024 *
-
Yield 2025 *
-
Free-Float 48.14%
More Fundamentals * Assessed data
Dynamic Chart
Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023. CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023. CI
Jafron Biomedical Co.,Ltd.'s Equity Buyback announced on July 17, 2023, has closed with 24,242,904 shares, representing 3% for CNY 500 million. CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023. CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhuhai Jianfu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 15 million in funding from Jafron Biomedical Co.,Ltd. CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023. CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jafron Biomedical Co.,Ltd. announces an Equity Buyback for CNY 500 million worth of its shares. CI
Jafron Biomedical Co.,Ltd. authorizes a Buyback Plan. CI
Jafron Biomedical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023 CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jafron Biomedical Co.,Ltd. Approves the Cash Dividend for 2022 CI
More news
1 day-1.55%
1 week+3.99%
Current month+3.99%
1 month+17.23%
3 months+40.74%
6 months+23.24%
Current year+28.83%
More quotes
1 week
27.83
Extreme 27.83
29.59
1 month
21.86
Extreme 21.86
29.59
Current year
15.88
Extreme 15.88
29.59
1 year
15.88
Extreme 15.88
29.67
3 years
15.88
Extreme 15.88
103.00
5 years
15.88
Extreme 15.88
103.00
10 years
6.82
Extreme 6.8211
103.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 98-12-31
Director/Board Member 45 12-12-31
Director/Board Member 54 09-12-31
Members of the board TitleAgeSince
Director/Board Member 62 23-04-20
Director/Board Member 51 23-04-20
Chief Executive Officer 54 98-12-31
More insiders
Date Price Change Volume
24-05-07 28.64 -1.55% 10 535 090
24-05-07 29.09 -1.09% 11,430,310
24-05-06 29.41 +6.79% 23,180,510
24-04-30 27.54 +1.62% 15,393,740

End-of-day quote Shenzhen S.E., May 07, 2024

More quotes
Jafron Biomedical Co.,Ltd. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Company’s products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Company’s products are applied in uremia, poisoning, severe liver diseases, autoimmune diseases, as well as multisystem organ failure, among others. The Company’s products are applied in 31 provinces, more than 3000 hospitals in China.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
28.64 CNY
Average target price
30.94 CNY
Spread / Average Target
+8.05%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300529 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW